The price typically includes your initial consultation, any necessary lab tests to establish a baseline, the peptides themselves, and all your follow-up visits to monitor progress
Tirzepatide (brand names Mounjaro and Zepbound): A dual-action medication that activates both GLP-1 and GIP receptors, tirzepatide has demonstrated even more impressive weight loss outcomes, with studies showing average weight loss of 15.0% to 20.9% of body weight
How It Works Experience the ease of at home IV therapy with comfort, convenience, and fast relief
There have not been many studies done regarding how much weight you can lose with lipotropic injections
Preclinical studies suggest GIP may enhance insulin secretion, improve beta-cell function, and influence adipose tissue metabolism differently than GLP-1
The placebo group recorded 0.7%